Medica Group Share Forecast, Price & News

GBX 160
+0.50 (+0.31 %)
(As of 05/7/2021 04:35 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume260,704 shs
Average Volume119,412 shs
Market Capitalization£195.83 million
P/E Ratio36.36
Dividend Yield1.07%
30 days | 90 days | 365 days | Advanced Chart
Receive MGP News and Ratings via Email

Sign-up to receive the latest news and ratings for Medica Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Devices
Phone44 33 3311 1222
Year FoundedN/A

Sales & Book Value

Annual Sales£41.55 million
Cash FlowGBX 18.21 per share
Book ValueGBX 33.10 per share





Market Cap£195.83 million
Next Earnings DateN/A


See More Headlines

About Medica Group

Medica Group Plc provides teleradiology reporting services to NHS trusts, private hospital groups, and diagnostic imaging companies in the United Kingdom. It offers NightHawk emergency computerised tomography (CT) and MR reporting, routine cross sectional, routine plain film, and radiographer plain film services. The company also provides audit services, such as cause for concern audit, departmental quality assurance, and ongoing CT, MR, plain film, and ultrasound audit services; and multiparametric prostate magnetic resonance imaging, specialist cardiac reporting, CT colonoscopy, DXA reporting, nuclear medicine examination, tailored cancer reporting, PET-CT, and CBCT services. Medica Group Plc was incorporated in 2013 and is based in Hastings, the United Kingdom.


Overall MarketRank

0.75 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Medica Group (LON:MGP) Frequently Asked Questions

Is Medica Group a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medica Group in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Medica Group stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MGP, but not buy additional shares or sell existing shares.
View analyst ratings for Medica Group
or view top-rated stocks.

What stocks does MarketBeat like better than Medica Group?

Wall Street analysts have given Medica Group a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Medica Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Medica Group's earnings last quarter?

Medica Group Plc (LON:MGP) posted its quarterly earnings data on Monday, September, 14th. The company reported $1.30 earnings per share for the quarter.
View Medica Group's earnings history

How has Medica Group's stock been impacted by COVID-19?

Medica Group's stock was trading at GBX 123 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MGP stock has increased by 30.1% and is now trading at GBX 160.
View which stocks have been most impacted by COVID-19

How often does Medica Group pay dividends? What is the dividend yield for Medica Group?

Medica Group announced a dividend on Wednesday, September 16th. Stockholders of record on Thursday, September 24th will be paid a dividend of GBX 0.85 per share on Friday, October 23rd. This represents a yield of 0.66%. The ex-dividend date is Thursday, September 24th. The official announcement can be viewed at this link.
View Medica Group's dividend history

Is Medica Group a good dividend stock?

Medica Group pays an annual dividend of GBX 0.01 per share and currently has a dividend yield of 1.07%. The dividend payout ratio of Medica Group is 0.19%. This payout ratio is at a healthy, sustainable level, below 75%.
View Medica Group's dividend history.

Who are Medica Group's key executives?

Medica Group's management team includes the following people:
  • Dr. Stuart Quin, CEO & Director
  • Dr. Stephen Griffith Davies, Medical Director, Responsible Officer & Exec. Director (Age 64, Pay $232k)
  • Mr. Richard Crispin Morgan Jones, CFO & Exec. Director (Age 55)
  • Ms. Sarah Burns, Chief Operating Officer
  • Mr. Marc O'Brien, Chief Information Officer
  • Ms. Julie West, Head of Governance & Compliance
  • Mr. David Evans, Head of Functional Architect
  • Mr. Gary Thompsett, Head of Service Delivery
  • Mr. Ben Tromans, Head of Service Devel. & Deployments
  • Mr. Ian Edwards, Head of Information Security & Risk

Who are some of Medica Group's key competitors?

What other stocks do shareholders of Medica Group own?

What is Medica Group's stock symbol?

Medica Group trades on the London Stock Exchange (LON) under the ticker symbol "MGP."

How do I buy shares of Medica Group?

Shares of MGP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Medica Group's stock price today?

One share of MGP stock can currently be purchased for approximately GBX 160.

How much money does Medica Group make?

Medica Group has a market capitalization of £195.83 million and generates £41.55 million in revenue each year.

How many employees does Medica Group have?

Medica Group employs 120 workers across the globe.

What is Medica Group's official website?

The official website for Medica Group is www.medicagroup.co.uk.

How can I contact Medica Group?

The company can be reached via phone at 44 33 3311 1222.

This page was last updated on 5/7/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.